✦ LIBER ✦

First-line bevacizumab-containing therapy for breast cancer: results in patients aged >=70 years treated in the ATHENA study

✍ Scribed by Biganzoli, L.; Di Vincenzo, E.; Jiang, Z.; Lichinitser, M.; Shen, Z.; Delva, R.; Bogdanova, N.; Vivanco, G. L.; Chen, Z.; Cheng, Y.; Just, M.; Espie, M.; Vinholes, J.; Hamm, C.; Crivellari, D.; Chmielowska, E.; Semiglazov, V.; Dalenc, F.; Smith, I.

Book ID: 119962844
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 185 KB
Volume: 23
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdr043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Bevacizumab-Containing Therap

First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study

✍ Thomssen, Christoph; Pierga, Jean-Yves; Pritchard, Kathleen I.; Biganzoli, Laura 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 375 KB

Efficacy and safety of the administratio

Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in Spanish patients

✍ EM Ciruelos, G López-Vivanco, I Peláez, J Rifa, A Santaballa… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 461 KB

Adding cetuximab to a standard chemother

Adding cetuximab to a standard chemotherapy regimen containing bevacizumab in first-line therapy for colorectal cancer decreases efficacy: Results from the CAIRO2 trial

✍ Axel Grothey 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 174 KB

470 Final results of a phase II study of

470 Final results of a phase II study of combination with nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy in patients with HER2-negative metastatic breast cancer

✍ S. Glück; C. Lobo; G. Lopes; A. Castrellon; J. Hurley; I. Reis; S. Richman; O. S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

5072 POSTER First-Line Bevacizumab (Bev)

5072 POSTER First-Line Bevacizumab (Bev) Combined With Paclitaxel (pac) in Older Patients (pts) Treated for HER2-Negative Metastatic Breast Cancer (mBC) in a Routine Oncology Practice Study

✍ Foerster, F.; Aktas, B.; Geberth, M.; Tschechne, B.; Schneeweiss, A.; Salat, C.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

5073 POSTER Bevacizumab (Bev) Combined W

5073 POSTER Bevacizumab (Bev) Combined With Paclitaxel (Pac) as First-line Therapy for Metastatic Triple-negative Breast Cancer (TNBC) -Analysis of 147 Patients (pts) Treated in Routine Oncology Practice in Germany

✍ Schneeweiss, A.; Foerster, F.; Hollburg, W.; Tesch, H.; Klare, P.; Wuelfing, P.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB